Europe Biological Skin Substitutes Market Size & Outlook
The biological skin substitutes market in Europe is expected to reach a projected revenue of US$ 152.4 million by 2033. A compound annual growth rate of 9% is expected of Europe biological skin substitutes market from 2026 to 2033.
Europe biological skin substitutes market highlights
The Europe biological skin substitutes market generated a revenue of USD 76.9 million in 2025.
The market is expected to grow at a CAGR of 9% from 2026 to 2033.
In terms of segment, human donor tissue-derived products was the largest revenue generating type in 2025.
Human Donor Tissue-Derived Products is the most lucrative type segment registering the fastest growth during the forecast period.
Country-wise, Germany is expected to register the highest CAGR from 2026 to 2033.
Europe data book summary
Market revenue in 2025
USD 76.9 million
Market revenue in 2033
USD 152.4 million
Growth rate
9% (CAGR from 2026 to 2033)
Largest segment
Human donor tissue-derived products
Fastest growing segment
Human Donor Tissue-Derived Products
Historical data covered
2021 - 2024
Base year for estimation
2025
Forecast period covered
2026 - 2033
Quantitative units
Revenue in USD million
Market segmentation
Acellular Animal-derived Products, Human Donor Tissue-Derived Products
Key market players worldwide
3M Co, Organogenesis Holdings Inc Class A, Integra Lifesciences Holdings Corp, Smith & Nephew PLC, MiMedx Group Inc, Essity AB Class B, Stryker Corp, Vericel Corp, Mallinckrodt PLC Ordinary Shares - New, Tissue Regenix
Other key industry trends
In terms of revenue, Europe region accounted for 20.4% of the global biological skin substitutes market in 2025.
Globally, North America is projected to lead the regional market in terms of revenue in 2033.
Asia Pacific is the fastest growing regional market and is projected to reach USD 232.5 million by 2033.
Europe is one of the most advanced regions globally with advanced technologies and infrastructure, resulting in better healthcare facilities and patient care. Players seeking entry into the Europe market require extensive knowledge regarding different regulatory procedures and services in various member states of the European Union.
Small and midsized medical device companies without a regulatory affairs department usually hire a regulatory consultant or a legal representative to assist them through the various stages of the regulatory approval processes required for commercializing their products in Europe. Medical device manufacturers in the EU are anticipated to face major changes in the old regulatory framework, which would affect market access or entry.
The EU Medical Device Regulations (MDR) are expected to replace the current Medical Device Directive (93/42/EEC) and the Directive on active implantable medical devices (90/385/EEC).
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Biological Skin Substitutes Market Outlook will help companies and investors design strategic landscapes.
Human Donor Tissue-Derived Products was the largest segment with a revenue share of 73.73% in 2025.
Horizon Databook has segmented the Europe biological skin substitutes market based on acellular animal-derived products, human donor tissue-derived products covering the revenue growth of each sub-segment from 2021 to 2033.
Europe is one of the most advanced regions globally with advanced technologies and infrastructure, resulting in better healthcare facilities and patient care. Players seeking entry into the Europe market require extensive knowledge regarding different regulatory procedures and services in various member states of the European Union.
Small and midsized medical device companies without a regulatory affairs department usually hire a regulatory consultant or a legal representative to assist them through the various stages of the regulatory approval processes required for commercializing their products in Europe. Medical device manufacturers in the EU are anticipated to face major changes in the old regulatory framework, which would affect market access or entry.
The EU Medical Device Regulations (MDR) are expected to replace the current Medical Device Directive (93/42/EEC) and the Directive on active implantable medical devices (90/385/EEC).
Europe Biological Skin Substitutes Market Type Outlook (Revenue, USD Million , 2021-2033)
Human Donor Tissue-Derived Products
Acellular Animal-derived Products
Europe Biological Skin Substitutes Market Application Outlook (Revenue, USD Million , 2021-2033)
Acute wounds
Chronic wounds
Europe Biological Skin Substitutes Market End-Use Outlook (Revenue, USD Million , 2021-2033)
Hospitals
Outpatient Facilities
Research and Manufacturing
Reasons to subscribe to Biological Skin Substitutes Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Biological Skin Substitutes Market Outlook databook
Our clientele includes a mix of Biological Skin Substitutes Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe Biological Skin Substitutes Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Europe Biological Skin Substitutes Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Europe Biological Skin Substitutes Market, 2021-2033 (US$M)